Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a Diabetes Care Editors’ Expert Forum
Open accessThe DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Abstract
Individualization of therapy based on a person’s specific type of diabetes is one key element of a “precision medicine” approach to diabetes care. However, applying such an approach remains difficult because of barriers such as disease heterogeneity, difficulties in accurately diagnosing different types of diabetes, multiple genetic influences, incomplete understanding of pathophysiology, limitations of current therapies, and environmental, social, and psychological factors. Monogenic diabetes, for which single gene mutations are causal, is the category most suited to a precision approach. The pathophysiological mechanisms of monogenic diabetes are understood better than those of any other form of diabetes. Thus, this category offers the advantage of accurate diagnosis of nonoverlapping etiological subgroups for which specific interventions can be applied. Although representing a small proportion of all diabetes cases, monogenic forms present an opportunity to demonstrate the feasibility of precision medicine strategies. In June 2019, the editors of Diabetes Care convened a panel of experts to discuss this opportunity. This article summarizes the major themes that arose at that forum. It presents an overview of the common causes of monogenic diabetes, describes some challenges in identifying and treating these disorders, and reports experience with various approaches to screening, diagnosis, and management. This article complements a larger American Diabetes Association effort supporting implementation of precision medicine for monogenic diabetes, which could serve as a platform for a broader initiative to apply more precise tactics to treating the more common forms of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Monogenic defects that cause b -cell dysfunction, such as neonatal diabetes and MODY, are present in a small fraction of people with diabetes ( < 5%) (155).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [155]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3)
Yamagata, K., Oda, N., Kaisaki, P. J., Menzel, S., Furuta, H., Vaxillaire, M., Southam, L., Cox, R. D., Lathrop, G. M., Boriraj, V. V., et al. (1996) · Nature · doi:10.1038/384455a0 · Cited by 1,614
Self-citationLifetime risk for diabetes mellitus in the United States
Narayan, K. M. V. (2003) · JAMA · doi:10.1001/jama.290.14.1884 · Cited by 1,515
Gloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., Howard, N., Srinivasan, S., Silva, J. M. C. L., Molnes, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032922 · Cited by 1,137
Self-citationSwitching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations
Pearson, E. R., Flechtner, I., Njølstad, P. R., Malecki, M. T., Flanagan, S. E., Larkin, B., Ashcroft, F. M., Klimes, I., Codner, E., Iotova, V., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061759 · Cited by 988
Self-citationMutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1)
Yamagata, K., Furuta, H., Oda, N., Kaisaki, P. J., Menzel, S., Cox, N. J., Fajans, S. S., Signorini, S., Stoffel, M., & Bell, G. I. (1996) · Nature · doi:10.1038/384458a0 · Cited by 976
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s009 · Cited by 914
Froguel, P., Zouali, H., Vionnet, N., Velho, G., Vaxillaire, M., Sun, F., Lesage, S., Stoffel, M., Takeda, J., Passa, P., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303113281005 · Cited by 735
Maturity-onset diabetes of the young (MODY): how many cases are we missing?
Shields, B. M., Hicks, S., Shepherd, M. H., Colclough, K., Hattersley, A. T., & Ellard, S. (2010) · Diabetologia · doi:10.1007/s00125-010-1799-4 · Cited by 725
Self-citationActivating Mutations in the ABCC8 Gene in Neonatal Diabetes Mellitus
Babenko, A. P., Polak, M., Cavé, H., Busiah, K., Czernichow, P., Scharfmann, R., Bryan, J., Aguilar-Bryan, L., Vaxillaire, M., & Froguel, P. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055068 · Cited by 655
Glucokinase as Glucose Sensor and Metabolic Signal Generator in Pancreatic β-Cells and Hepatocytes
Matschinsky, F. M. (1990) · Diabetes · doi:10.2337/diab.39.6.647 · Cited by 619
Genetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607 · cited 1×
“Similarly, insulin therapy may be prescribed unnecessarily for HNF1A-MODY, which is highly responsive to sulfonylurea therapy (43).”
BackgroundSelf-citationInsulin gene mutations as a cause of permanent neonatal diabetes
Støy, J., Edghill, E. L., Flanagan, S. E., Ye, H., Paz, V. P., Pluzhnikov, A., Below, J. E., Hayes, M. G., Cox, N. J., Lipkind, G. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707291104 · Cited by 564
Self-citationThe Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline
Brown, R. J., Araujo-Vilar, D., Cheung, P. T., Dunger, D., Garg, A., Jack, M., Mungai, L., Oral, E. A., Patni, N., Rother, K. I., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2466 · Cited by 529
Balsells, M., Garcia-Patterson, A., Sola, I., Roque, M., Gich, I., & Corcoy, R. (2015) · BMJ · doi:10.1136/bmj.h102 · Cited by 498
Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young
Ellard, S., Bellanné-Chantelot, C., Hattersley, A. T., & European Molecular Genetics Quality Network (EMQN) MODY group (2008) · Diabetologia · doi:10.1007/s00125-008-0942-y · Cited by 433
Self-citationPearson, E. R., Boj, S. F., Steele, A. M., Barrett, T., Stals, K., Shield, J. P., Ellard, S., Ferrer, J., & Hattersley, A. T. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040118 · Cited by 427
Self-citationChung, W. K., Erion, K., Florez, J. C., Hattersley, A. T., Hivert, M.-F., Lee, C. G., McCarthy, M. I., Nolan, J. J., Norris, J. M., Pearson, E. R., et al. (2020) · Diabetes Care · doi:10.2337/dci20-0022 · Cited by 400
Self-citationPihoker, C., Gilliam, L. K., Ellard, S., Dabelea, D., Davis, C., Dolan, L. M., Greenbaum, C. J., Imperatore, G., Lawrence, J. M., Marcovina, S. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1279 · Cited by 397
Self-citationSteele, A. M., Shields, B. M., Wensley, K. J., Colclough, K., Ellard, S., & Hattersley, A. T. (2014) · JAMA · doi:10.1001/jama.2013.283980 · Cited by 381
Self-citationFlanagan, S. E., Patch, A.-M., Mackay, D. J. G., Edghill, E. L., Gloyn, A. L., Robinson, D., Shield, J. P. H., Temple, K., Ellard, S., & Hattersley, A. T. (2007) · Diabetes · doi:10.2337/db07-0043 · Cited by 357
Self-citationHNF1B-associated renal and extra-renal disease—an expanding clinical spectrum
Clissold, R. L., Hamilton, A. J., Hattersley, A. T., Ellard, S., & Bingham, C. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.232 · Cited by 352
Self-citationDe Franco, E., Flanagan, S. E., Houghton, J. A., Allen, H. L., Mackay, D. J., Temple, I. K., Ellard, S., & Hattersley, A. T. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60098-8 · Cited by 349
Self-citationShields, B. M., McDonald, T. J., Ellard, S., Campbell, M. J., Hyde, C., & Hattersley, A. T. (2012) · Diabetologia · doi:10.1007/s00125-011-2418-8 · Cited by 335
Self-citationFajans, S. S., & Bell, G. I. (2011) · Diabetes Care · doi:10.2337/dc11-0035 · Cited by 320
Hattersley, A. T., Greeley, S. A. W., Polak, M., Rubio-Cabezas, O., Njølstad, P. R., Mlynarski, W., Castano, L., Carlsson, A., Raile, K., Chi, D. V., et al. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12772 · Cited by 319
Self-citationWolfram Syndrome: Diagnosis, Management, and Treatment
Urano, F. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0702-6 · Cited by 307
Precision diabetes: learning from monogenic diabetes
Hattersley, A. T., & Patel, K. A. (2017) · Diabetologia · doi:10.1007/s00125-017-4226-2 · Cited by 306
Self-citationInsulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations.
Byrne, M. M., Sturis, J., Clément, K., Vionnet, N., Pueyo, M. E., Stoffel, M., Takeda, J., Passa, P., Cohen, D., & Bell, G. I. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117064 · Cited by 300
Murphy, R., Turnbull, D. M., Walker, M., & Hattersley, A. T. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02359.x · Cited by 291
Self-citationChakera, A. J., Steele, A. M., Gloyn, A. L., Shepherd, M. H., Shields, B., Ellard, S., & Hattersley, A. T. (2015) · Diabetes Care · doi:10.2337/dc14-2769 · Cited by 289
Self-citationShepherd, M., Shields, B., Ellard, S., Rubio‐Cabezas, O., & Hattersley, A. T. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02690.x · Cited by 241
Self-citationShepherd, M., Shields, B., Hammersley, S., Hudson, M., McDonald, T. J., Colclough, K., Oram, R. A., Knight, B., Hyde, C., Cox, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0645 · Cited by 236
Self-citationProks, P., Antcliff, J. F., Lippiat, J., Gloyn, A. L., Hattersley, A. T., & Ashcroft, F. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404756101 · Cited by 234
Self-citationPearson, E. R., Pruhova, S., Tack, C. J., Johansen, A., Castleden, H. A. J., Lumb, P. J., Wierzbicki, A. S., Clark, P. M., Lebl, J., Pedersen, O., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1738-y · Cited by 232
Self-citationMcDonald, T. J., Colclough, K., Brown, R., Shields, B., Shepherd, M., Bingley, P., Williams, A., Hattersley, A. T., & Ellard, S. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03287.x · Cited by 229
Self-citationEllard, S., Flanagan, S. E., Girard, C. A., Patch, A.-M., Harries, L. W., Parrish, A., Edghill, E. L., Mackay, D. J. G., Proks, P., Shimomura, K., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519174 · Cited by 215
Self-citationStride, A., Shields, B., Gill-Carey, O., Chakera, A. J., Colclough, K., Ellard, S., & Hattersley, A. T. (2014) · Diabetologia · doi:10.1007/s00125-013-3075-x · Cited by 212
Self-citationRecessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis
Garin, I., Edghill, E. L., Akerman, I., Rubio-Cabezas, O., Rica, I., Locke, J. M., Maestro, M. A., Alshaikh, A., Bundak, R., del Castillo, G., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910533107 · Cited by 211
Self-citationProks, P., Arnold, A. L., Bruining, J., Girard, C., Flanagan, S. E., Larkin, B., Colclough, K., Hattersley, A. T., Ashcroft, F. M., & Ellard, S. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl101 · Cited by 211
Self-citationEllard, S., Beards, F., Allen, L. I. S., Shepherd, M., Ballantyne, E., Harvey, R., & Hattersley, A. T. (2000) · Diabetologia · doi:10.1007/s001250050038 · Cited by 209
Self-citationGidh-Jain, M., Takeda, J., Xu, L. Z., Lange, A. J., Vionnet, N., Stoffel, M., Froguel, P., Velho, G., Sun, F., & Cohen, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1932 · Cited by 201
Relapsing diabetes can result from moderately activating mutations in KCNJ11
Gloyn, A. L., Reimann, F., Girard, C., Edghill, E. L., Proks, P., Pearson, E. R., Temple, I. K., Mackay, D. J. G., Shield, J. P. H., Freedenberg, D., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi086 · Cited by 197
Self-citationThe diagnosis and management of monogenic diabetes in children and adolescents
Rubio-Cabezas, O., Hattersley, A. T., Njølstad, P. R., Mlynarski, W., Ellard, S., White, N., Chi, D. V., & Craig, M. E. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12192 · Cited by 196
Self-citationUpdate on Diabetes Classification
Thomas, C. C., & Philipson, L. H. (2015) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.08.015 · Cited by 180
Self-citationHeterozygous ABCC8 mutations are a cause of MODY
Bowman, P., Flanagan, S. E., Edghill, E. L., Damhuis, A., Shepherd, M. H., Paisey, R., Hattersley, A. T., & Ellard, S. (2012) · Diabetologia · doi:10.1007/s00125-011-2319-x · Cited by 177
Self-citationBowman, P., Sulen, Å., Barbetti, F., Beltrand, J., Svalastoga, P., Codner, E., Tessmann, E. H., Juliusson, P. B., Skrivarhaug, T., Pearson, E. R., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30106-2 · Cited by 175
Self-citationDe Franco, E., Saint‐Martin, C., Brusgaard, K., Knight Johnson, A. E., Aguilar‐Bryan, L., Bowman, P., Arnoux, J., Larsen, A. R., Sanyoura, M., Greeley, S. A. W., et al. (2020) · Human Mutation · doi:10.1002/humu.23995 · Cited by 174
Self-citationDocherty, L. E., Kabwama, S., Lehmann, A., Hawke, E., Harrison, L., Flanagan, S. E., Ellard, S., Hattersley, A. T., Shield, J. P. H., Ennis, S., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2832-1 · Cited by 173
Self-citationChakera, A. J., Spyer, G., Vincent, N., Ellard, S., Hattersley, A. T., & Dunne, F. P. (2014) · Diabetes Care · doi:10.2337/dc13-2248 · Cited by 154
Self-citationShields, B. M., Shepherd, M., Hudson, M., McDonald, T. J., Colclough, K., Peters, J., Knight, B., Hyde, C., Ellard, S., Pearson, E. R., et al. (2017) · Diabetes Care · doi:10.2337/dc17-0224 · Cited by 151
Self-citationHeterozygous RFX6 protein truncating variants are associated with MODY with reduced penetrance
Patel, K., Kettunen, J. L. T., Laakso, M., Stančáková, A., Laver, T. W., Colclough, K., Johnson, M. B., Abramowicz, M., Groop, L., Miettinen, P. J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00895-9 · Cited by 149
Self-citationDiazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations
Flanagan, S. E., Kapoor, R. R., Mali, G., Cody, D., Murphy, N., Schwahn, B., Siahanidou, T., Banerjee, I., Akcay, T., Rubio-Cabezas, O., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0861 · Cited by 144
Naylor, R. N., John, P. M., Winn, A. N., Carmody, D., Greeley, S. A. W., Philipson, L. H., Bell, G. I., & Huang, E. S. (2014) · Diabetes Care · doi:10.2337/dc13-0410 · Cited by 134
Self-citationJohansson, B. B., Irgens, H. U., Molnes, J., Sztromwasser, P., Aukrust, I., Júlíusson, P. B., Sövik, O., Levy, S., Skrivarhaug, T., Joner, G., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-4167-1 · Cited by 134
Steele, A. M., Wensley, K. J., Ellard, S., Murphy, R., Shepherd, M., Colclough, K., Hattersley, A. T., & Shields, B. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065326 · Cited by 133
Self-citationSpyer, G., Macleod, K. M., Shepherd, M., Ellard, S., & Hattersley, A. T. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02622.x · Cited by 130
Self-citationMenzel, R., Kaisaki, P. J., Rjasanowski, I., Heinke, P., Kerner, W., & Menzel, S. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199810)15:10<816::aid-dia714>3.0.co;2-p · Cited by 127
Diagnosis and treatment of neonatal diabetes: an United States experience†
Støy, J., Greeley, S. A. W., Paz, V. P., Ye, H., Pastore, A. N., Skowron, K. B., Lipton, R. B., Cogen, F. R., Bell, G. I., Philipson, L. H., et al. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00433.x · Cited by 126
Self-citationStride, A., Ellard, S., Clark, P., Shakespeare, L., Salzmann, M., Shepherd, M., & Hattersley, A. T. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1751 · Cited by 126
Self-citationA Global Overview of Precision Medicine in Type 2 Diabetes
Fitipaldi, H., McCarthy, M. I., Florez, J. C., & Franks, P. W. (2018) · Diabetes · doi:10.2337/dbi17-0045 · Cited by 122
Self-citationNew insights into KATP channel gene mutations and neonatal diabetes mellitus
Pipatpolkai, T., Usher, S., Stansfeld, P. J., & Ashcroft, F. M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0351-y · Cited by 122
Carlsson, A., Shepherd, M., Ellard, S., Weedon, M., Lernmark, Å., Forsander, G., Colclough, K., Brahimi, Q., Valtonen-Andre, C., Ivarsson, S. A., et al. (2020) · Diabetes Care · doi:10.2337/dc19-0747 · Cited by 111 · cited 5×
“5th percentile for one ormore autoantibodies donot need tobe tested for MODY (11,13).”
BackgroundInfluentialSelf-citationMaturity-Onset Diabetes of the Young in Children With Incidental Hyperglycemia:
Lorini, R., Klersy, C., d'Annunzio, G., Massa, O., Minuto, N., Iafusco, D., Bellannè-Chantelot, C., Frongia, A. P., Toni, S., Meschi, F., et al. (2009) · Diabetes Care · doi:10.2337/dc08-2018 · Cited by 110
study, F. T. U., Shepherd, M. H., Shields, B. M., Hudson, M., Pearson, E. R., Hyde, C., Ellard, S., Hattersley, A. T., & Patel, K. A. (2018) · Diabetologia · doi:10.1007/s00125-018-4728-6 · Cited by 109
Self-citationDelvecchio, M., Mozzillo, E., Salzano, G., Iafusco, D., Frontino, G., Patera, P. I., Rabbone, I., Cherubini, V., Grasso, V., Tinto, N., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2490 · Cited by 107
Shah, R. P., Spruyt, K., Kragie, B. C., Greeley, S. A. W., & Msall, M. E. (2012) · Diabetes Care · doi:10.2337/dc11-2225 · Cited by 94
Self-citationThe Cost-Effectiveness of Personalized Genetic Medicine
Greeley, S. A. W., John, P. M., Winn, A. N., Ornelas, J., Lipton, R. B., Philipson, L. H., Bell, G. I., & Huang, E. S. (2011) · Diabetes Care · doi:10.2337/dc10-1616 · Cited by 85
Self-citationCarmody, D., Naylor, R. N., Bell, C. D., Berry, S., Montgomery, J. T., Tadie, E. C., Hwang, J. L., Greeley, S. A. W., & Philipson, L. H. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0859-8 · Cited by 84
Self-citationDickens, L. T., Letourneau, L. R., Sanyoura, M., Greeley, S. A. W., Philipson, L. H., & Naylor, R. N. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1267-z · Cited by 80
Self-citationShankar, R. K., Pihoker, C., Dolan, L. M., Standiford, D., Badaru, A., Dabelea, D., Rodriguez, B., Black, M. H., Imperatore, G., Hattersley, A., et al. (2012) · Pediatric Diabetes · doi:10.1111/pedi.12003 · Cited by 76
Self-citationRubioCabezas, O., Flanagan, S. E., Damhuis, A., Hattersley, A. T., & Ellard, S. (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00824.x · Cited by 73
Self-citationPersistently autoantibody negative (PAN) type 1 diabetes mellitus in children
Hameed, S., Ellard, S., Woodhead, H. J., Neville, K. A., Walker, J. L., Craig, M. E., Armstrong, T., Yu, L., Eisenbarth, G. S., Hattersley, A. T., et al. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00681.x · Cited by 72
Self-citationSørgjerd, E. P., Thorsby, P. M., Torjesen, P. A., Skorpen, F., Kvaløy, K., & Grill, V. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2014-000076 · Cited by 71
on behalf of the Monogenic Diabetes Study Group of the Société Francophone du Diabète, Donath, X., Saint‐Martin, C., Dubois‐Laforgue, D., Rajasingham, R., Mifsud, F., Ciangura, C., Timsit, J., & Bellanné‐Chantelot, C. (2019) · BMC Medicine · doi:10.1186/s12916-019-1363-0 · Cited by 71
Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents
Feigerlová, E., Průhová, Š., Dittertová, L., Lebl, J., Pintérová, D., Kološtová, K., Černá, M., Pedersen, O. B., & Hansen, T. F. (2006) · European Journal of Pediatrics · doi:10.1007/s00431-006-0106-3 · Cited by 59
Mohamadi, A., Clark, L. M., Lipkin, P. H., Mahone, E. M., Wodka, E. L., & Plotnick, L. P. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00548.x · Cited by 58
Clinical Management of Women with Monogenic Diabetes During Pregnancy
Dickens, L. T., & Naylor, R. N. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0982-8 · Cited by 58
Monogenic autoimmune diseases of the endocrine system
Johnson, M. B., Hattersley, A. T., & Flanagan, S. E. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30095-x · Cited by 54
Self-citationCaswell, R. C., Snowsill, T., Houghton, J., Chakera, A. J., Shepherd, M. H., Laver, T. W., Knight, B., Wright, D. E., Hattersley, A. T., & Ellard, S. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa104 · Cited by 50
Self-citationTreatment of young patients with HNF1A mutations (HNF1A–MODY)
Raile, K., Schober, E., Konrad, K., Thon, A., Grulich‐Henn, J., Meissner, T., Wölfle, J., Scheuing, N., Holl, R. W., & the DPV Initiative the German BMBF Competence Network Diabetes Mellitus (2015) · Diabetic Medicine · doi:10.1111/dme.12662 · Cited by 49
Hosoe, J., Kadowaki, H., Miya, F., Aizu, K., Kawamura, T., Miyata, I., Satomura, K., Ito, T., Hara, K., Tanaka, M., et al. (2017) · Diabetes · doi:10.2337/db17-0301 · Cited by 47
Chakera, A. J., Hurst, P. S., Spyer, G., Ogunnowo-Bada, E. O., Marsh, W. J., Riches, C. H., Yueh, C.-Y., Markkula, S. P., Dalley, J. W., Cox, R. D., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.08.001 · Cited by 46
Self-citationShepherd, M. H., Brook, A., Chakera, A. J., & Hattersley, A. T. (2017) · Diabetic Medicine · doi:10.1111/dme.13388 · Cited by 43
Self-citationGoodSmith, M. S., Skandari, M. R., Huang, E. S., & Naylor, R. N. (2019) · Diabetes Care · doi:10.2337/dc19-0486 · Cited by 41
Targeted sequencing identifies novel variants in common and rare MODY genes
de Santana, L. S., Caetano, L. A., Costa‐Riquetto, A. D., Franco, P. C., Dotto, R. P., Reis, A. F., Weinert, L. S., Silveiro, S. P., Vendramini, M. F., do Prado, F. A., et al. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.962 · Cited by 41
Precision Medicine for Managing Diabetes
Klonoff, D. C. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814563643 · Cited by 39
Ellard, S., Colclough, K., Patel, K. A., & Hattersley, A. T. (2019) · Journal of Clinical Investigation · doi:10.1172/jci133516 · Cited by 38
Self-citationKřížková, K., Veverka, V., Maletínská, L., Hexnerova, R., Brzozowski, A. M., Jiráček, J., & Žáková, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112883 · Cited by 30
Carmody, D., Beca, F. A., Bell, C. D., Hwang, J. L., Dickens, J. T., Devine, N. A., Mackay, D., Temple, I. K., Hays, L. R., Naylor, R. N., et al. (2015) · Diabetes Care · doi:10.2337/dc14-3056 · Cited by 30
Self-citationContinued lessons from the INS gene: an intronic mutation causing diabetes through a novel mechanism
Carmody, D., Park, S.-Y., Ye, H., Perrone, M. E., Alkorta‐Aranburu, G., Highland, H. M., Hanis, C. L., Philipson, L. H., Bell, G. I., & Greeley, S. A. W. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103220 · Cited by 30
Self-citationEthel Codner, D., Rocha, A., Deng, L., Martínez‐Aguayo, A., Godoy, C., Verónica Mericq, G., & Chung, W. K. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00499.x · Cited by 28
Lanning, M. S., Carmody, D., Szczerbiński, Ł., Letourneau, L. R., Naylor, R. N., & Greeley, S. A. W. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12599 · Cited by 27
Self-citationA Clinical Guide to Monogenic Diabetes
Carmody, D., Støy, J., Greeley, S. A. W., Bell, G. I., & Philipson, L. H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800892-8.00002-6 · Cited by 25
Self-citationShepherd, M. H., Colclough, K., Ellard, S., & Hattersley, A. T. (2014) · Clinical Medicine · doi:10.7861/clinmedicine.14-2-117 · Cited by 20
Self-citationStøy, J., Olsen, J., Park, S. Y., Gregersen, S., Hjørringgaard, C. U., & Bell, G. I. (2017) · Diabetologia · doi:10.1007/s00125-017-4295-2 · Cited by 19
Management and Outcomes of Maturity-Onset Diabetes of the Young in Pregnancy
Monsonego, S., Clark, H. D., Karovitch, A. J., O’Meara, P., Shaw, T., & Malcolm, J. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.07.004 · Cited by 18
The Impact of Precision Medicine in Diabetes: A Multidimensional Perspective
Rich, S. S., & Cefalu, W. T. (2016) · Diabetes Care · doi:10.2337/dc16-1833 · Cited by 17
Self-citationLetourneau, L. R., & Greeley, S. A. W. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1016-2 · Cited by 17
Self-citationLetourneau, L. R., Carmody, D., Philipson, L. H., & Greeley, S. A. W. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00356 · Cited by 15
Self-citationBowman, P., McDonald, T. J., Knight, B., Flanagan, S. E., Leveridge, M., Spaull, S. R., Shields, B. M., Hammersley, S., Shepherd, M. H., Andrews, R. C., et al. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000721 · Cited by 12
Self-citationStrategies to identify individuals with monogenic diabetes: results of an economic evaluation
Peters, J., Anderson, R., Shields, B. M., King, S., Hudson, M., Shepherd, M. H., McDonald, T. J., Pearson, E. R., Hattersley, A. T., & Hyde, C. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034716 · Cited by 12
Self-citation
Cited by
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Chung, W. K., Erion, K., Florez, J. C., Hattersley, A. T., Hivert, M.-F., Lee, C. G., McCarthy, M. I., Nolan, J. J., Norris, J. M., Pearson, E. R., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05181-w · Cited by 203
Self-citationBonnefond, A., Unnikrishnan, R., Doria, A., Vaxillaire, M., Kulkarni, R., Mohan, V., Trischitta, V., & Froguel, P. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00421-w · Cited by 190
Personalized type 2 diabetes management: an update on recent advances and recommendations
Williams, D. M., Jones, H., & Stephens, J. W. (2022) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s331654 · Cited by 121
Metadata
- Authors
- Riddle, M. C., Philipson, L. H., Rich, S. S., Carlsson, A., Franks, P. W., Greeley, S. A. W., Nolan, J. J., Pearson, E. R., Zeitler, P. S., & Hattersley, A. T.
- Affiliations
- Oregon Health & Science University (US)
- University of Chicago (US)
- University of Virginia (US)
- Lund University (SE)
- Harvard University (US)
- Trinity College Dublin (IE)
- University of Dundee (GB)
- Children's Hospital Colorado (US)
- University of Exeter (GB)
- Corresponding author
- Riddle, Matthew C.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-11-12
- Volume
- 43
- Issue
- 12
- Pages
- 3117-3128
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC8162450
- OpenAlex
- W3106034474
- Cited by
- 117
- References
- 103
- Citations by year
- 2026: 24 · 2025: 9 · 2024: 21 · 2023: 23 · 2022: 23 · 2021: 16 · 2020: 1
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion, other-oa)
- Open Research Exeter (University of Exeter) (acceptedVersion)
- Figshare (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Wellcome Trust (102820/Z/13/Z)
- National Institute for Health and Care Research (NF-SI-0611-10219)
- Novo Nordisk Fonden (NNF18OC0034050, NNF14OC0011039, NNF17OC0026828)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK104942, P30DK020595)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- monogenic diabetes, precision medicine, genetic diagnosis, disease heterogeneity, screening, diagnosis, diabetes management, pathophysiology, genetic mutations, expert consensus
- MeSH terms
- Congresses as Topic, Diabetes Mellitus, Endocrinology, Expert Testimony, Humans, Patient-Centered Care, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.